Prestige Consumer Healthcare Reports Q4 Revenue and Earnings Miss
Prestige Consumer Healthcare reported fiscal Q4 revenue of $281.6 million, missing FactSet estimates of $293.6 million. The company also reported adjusted EPS of $1.23, below the estimated $1.39. Despite the miss, Prestige Consumer delivered resilient cash flow and has announced an acquisition.
Prestige Consumer Healthcare (PBH) reported its Q4 earnings, revealing a revenue miss in the process. According to FactSet estimates, the company's Q4 revenue was $293.6 million, but the actual revenue came in at $281.6 million.
The earnings release also reported adjusted EPS of $1.23, which fell short of the predicted $1.39. These figures indicate a challenging quarter for Prestige Consumer in terms of revenue and earnings growth.
Despite the Q4 revenue decline, the company demonstrated resilient cash flow during its fiscal 2026. Furthermore, Prestige Consumer has made significant strides with the announcement of the LaCorium acquisition, which could signal strategic growth and expansion.
Investors closely watched Prestige's Q4 reports, considering the company's key metrics and the impact of revenue challenges. Additionally, a comparison of actual EPS to the expected EPS provides another data point for analysis.
Related Stocks
Powered by SentiSense - Intelligent Market Analysis